Sign In
Buy ESTA
$72.41
+2.00 (+2.84%)
At Close: Jun 03, 2026
Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants®
12:00pm, Thursday, 06'th Mar 2025
The campaign is the first-of-its-kind partnership and follows the US FDA approval of Motiva Implants® NEW YORK , March 6, 2025 /PRNewswire/ -- Establishment Labs® Holdings Inc. (NASDAQ: ESTA), a
Establishment Labs Holdings Inc. (ESTA) Q4 2024 Earnings Call Transcript
08:56pm, Wednesday, 26'th Feb 2025
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Raj Denhoy - CFO Juan Chacón-Quirós - CEO Peter Caldini - President
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Lags Revenue Estimates
06:11pm, Wednesday, 26'th Feb 2025
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.98 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $0.79 per share a year ago.
Establishment Labs Reports Fourth Quarter and Full Year 2024 Financial Results and Reaffirms 2025 Guidance
04:00pm, Wednesday, 26'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Present at Citi's 2025 Unplugged Medtech and Life Sciences Access Day
08:00am, Friday, 21'st Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Launches Preservé™
08:00am, Tuesday, 18'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness in breast aesthetics and reconstructi
Establishment Labs to Announce Fourth Quarter 2024 Financial Results on February 26
08:00am, Friday, 14'th Feb 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08:00am, Tuesday, 07'th Jan 2025
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript
08:55am, Saturday, 09'th Nov 2024
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Co
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates
06:21pm, Thursday, 07'th Nov 2024
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $1.12 per share a year ago.
Establishment Labs Announces $50 Million Registered Direct Offering
05:20pm, Thursday, 07'th Nov 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in b
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
08:00am, Thursday, 31'st Oct 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc (ESTA) Stock Price Up 9.25% on Oct 2
12:07pm, Wednesday, 02'nd Oct 2024
Shares of Establishment Labs Holdings Inc (ESTA, Financial) surged 9.25% in mid-day trading on Oct 2. The stock reached an intraday high of $44.42, before settling at $44.31, up from its previous clos
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
05:02pm, Thursday, 26'th Sep 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
06:16pm, Tuesday, 06'th Aug 2024
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago.
